Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sonoma Pharmaceuticals Inc SNOA

Healthcare
Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SNOA)

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Accesswire 7 days ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Accesswire November 11, 2024

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Accesswire November 7, 2024

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Accesswire October 31, 2024

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Accesswire October 22, 2024

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Accesswire October 21, 2024

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Accesswire September 19, 2024

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Accesswire September 17, 2024

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Accesswire September 11, 2024
View More News ››

Opinion & Analysis (NDAQ:SNOA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SNOA)

Sonoma Pharmaceuticals Announces Expanded Partnership with G

BREAKING NEWS: $SNOA Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound...
whytestocks - October 22, 2024

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance wit

News; $SNOA Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based...
whytestocks - September 17, 2024

Sonoma Pharmaceuticals (NASDAQ:SNOA) Poised for Growth with

http://beyondspx.com/2024/08/01/sonoma-pharmaceuticals-nasdaqsnoa-poised-for-growth-with-innovative-hypochlorous-acid-products/
MikeTester - August 2, 2024

Last call at .22

Final rush to .25
Nibinator - December 5, 2023

Try a buy around .26 this morning

High on hopes
Nibinator - December 5, 2023

SNOA .... Vols are light today but it's still trying ; )

The $2.10 target is still a pivot for today A volume spike would be a good catalyst  GL
Iseneschal - January 26, 2023
View more Bullboard ››

Benton Resources Inc.

Benton Resources Inc.

Benton Resources Inc. is a mineral exploration company listed on the TSX Venture Exchange under the symbol BEX. Benton has a ...
View More »